Sugi Predict

Sugi Predict / Compounds / SCHEMBL4862857

SCHEMBL4862857

SCHEMBL4862857

C=COCCON1C(=O)c2ccccc2C1=O

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.66
▸ ALDH1A1 P00352 5/20 0.62
▸ CYP1A2 P05177 2/20 0.48
▸ RECQL P46063 1/20 0.48
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.43
▸ HTT P42858 1/20 0.42
▸ ATM Q13315 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30226348 1.00 GAA (0.66) GAAALDH1A1CYP1A2RECQLKMT2A
SCHEMBL6291657 0.92 GAA (0.57) GAAALDH1A1CYP1A2RECQLKMT2A
SCHEMBL6291660 0.92 GAA (0.57) GAAALDH1A1CYP1A2RECQLKMT2A
Vinyl Ether SCHEMBL6291654 0.90 GAA (0.54) GAAALDH1A1CYP1A2RECQLKMT2A
SCHEMBL22326350 0.85 GAA (0.88) GAAALDH1A1CYP1A2RECQLKMT2A
SCHEMBL24370531 0.81 ALDH1A1 (0.69) GAAALDH1A1CYP1A2RECQLKMT2A
SCHEMBL30804996 0.80 GAA (0.72) GAAALDH1A1CYP1A2RECQLKMT2A
SCHEMBL1038374 0.80 GAA (0.72) GAAALDH1A1CYP1A2RECQLKMT2A
SCHEMBL29328604 0.80 GAA (0.77) GAAALDH1A1CYP1A2RECQLKMT2A
SCHEMBL12028883 0.80 GAA (1.00) GAAALDH1A1CYP1A2RECQLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115895532-A Single-layer photovoltaic packaging adhesive film and preparation method thereof 万华化学集团股份有限公司 2023-04-04 — — CN claimed
CN-115895532-A Single-layer photovoltaic packaging adhesive film and preparation method thereof 万华化学集团股份有限公司 2023-04-04 — — CN disclosed
EP-3481822-B1 MULTIFUNCTIONAL INHIBITORS OF MEK/PI3K AND MTOR/MEK/PI3K BIOLOGICAL PATHWAYS AND THERAPEUTIC METHODS USING THE SAME UNIV MICHIGAN REGENTS (US) 2022-06-22 — — EP disclosed
US-10919877-B2 Multifunctional inhibitors of MEK/PI3K and mTOR/MEK/PI3K biological pathways and therapeutic methods using the same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2021-02-16 — — US disclosed
US-20190224207-A1 MULTIFUNCTIONAL INHIBITORS OF MEK/PI3K AND mTOR/MEK/PI3K BIOLOGICAL PATHWAYS AND THERAPEUTIC METHODS USING THE SAME NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2019-07-25 — — US disclosed
EP-1301472-B1 OXYGENATED ESTERS OF 4-IODO PHENYLAMINO BENZHYDROXAMIC ACIDS WARNER LAMBERT CO (US) 2014-03-26 — — EP disclosed
US-20120238599-A1 HETEROCYCLIC COMPOUNDS AS MEK INHIBITORS CHEMIZON, A DIVISION OF OPTOMAGIC CO., LTD. (KR) 2012-09-20 — — US disclosed
US-20120238599-A1 HETEROCYCLIC COMPOUNDS AS MEK INHIBITORS CHEMIZON, A DIVISION OF OPTOMAGIC CO., LTD. (KR) 2012-09-20 — — US disclosed
US-20120238599-A1 HETEROCYCLIC COMPOUNDS AS MEK INHIBITORS CHEMIZON, A DIVISION OF OPTOMAGIC CO., LTD. (KR) 2012-09-20 — — US disclosed
US-7411001-B2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY (US) 2008-08-12 — — US disclosed
US-6960614-B2 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY (US) 2005-11-01 — — US disclosed
US-20050176820-A1 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY 2005-08-11 — — US disclosed
US-20040054172-A1 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY 2004-03-18 — — US disclosed
EP-1301472-A2 OXYGENATED ESTERS OF 4-IODO PHENYLAMINO BENZHYDROXAMIC ACIDS WARNER-LAMBERT COMPANY (US) 2003-04-16 — — EP disclosed
WO-2002006213-A2 OXYGENATED ESTERS OF 4-IODO PHENYLAMINO BENZHYDROXAMIC ACIDS WARNER-LAMBERT COMPANY (US) 2002-01-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176820-A1 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids CYP4X1, CYP2A7, CYP4B1 GAA 818/4885ALDH1A1 157/4885CYP1A2 12/4885
US-20040054172-A1 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids CYP4X1, ALOX5, HAAO GAA 519/4885ALDH1A1 200/4885CYP1A2 12/4885
US-10919877-B2 Multifunctional inhibitors of MEK/PI3K and mTOR/MEK/PI3K biological pathways and therapeutic methods using the same MTOR, PIK3CA, MAPKAP1 GAA 887/4885ALDH1A1 4507/4885CYP1A2 4655/4885
US-20120238599-A1 HETEROCYCLIC COMPOUNDS AS MEK INHIBITORS BRAF, MAP3K1, MAP3K11 GAA 3365/4885ALDH1A1 2039/4885CYP1A2 425/4885
US-20190224207-A1 MULTIFUNCTIONAL INHIBITORS OF MEK/PI3K AND mTOR/MEK/PI3K BIOLOGICAL PATHWAYS AND THERAPEUTIC METHODS USING THE SAME MTOR, PIK3CA, MAPKAP1 GAA 887/4885ALDH1A1 4507/4885CYP1A2 4655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.